UCB Pharma GmbH
- ISIN DE0007221905
- Country Deutschland
Company profile
SCHWARZ PHARMA AG (headquartered in Monheim, Germany) is a member of UCB-Group, Brussels, Belgium (www.ucb-group.com).
UCB is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialization of innovative medicines with focus on the fields of central nervous system and immunology. Employing around 12,000 people in over 40 countries, UCB achieved revenue of over 3.3 billion euro in 2008. UCB is listed on the Euronext Brussels Exchange and owns approx. 95 % of the shares of SCHWARZ PHARMA AG.